166 related articles for article (PubMed ID: 8490076)
1. Proton pump inhibitors, enterochromaffin-like cell growth and Helicobacter pylori gastritis.
Solcia E; Villani L; Luinetti O; Fiocca R
Aliment Pharmacol Ther; 1993; 7 Suppl 1():25-8, discussion 29-31. PubMed ID: 8490076
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole.
Hirschowitz BI; Haber MM
Aliment Pharmacol Ther; 2001 Jan; 15(1):87-103. PubMed ID: 11136282
[TBL] [Abstract][Full Text] [Related]
3. Sporadic duodenal bulb gastrin-cell tumors: association with Helicobacter pylori gastritis and long-term use of proton pump inhibitors.
Merchant SH; VanderJagt T; Lathrop S; Amin MB
Am J Surg Pathol; 2006 Dec; 30(12):1581-7. PubMed ID: 17122515
[TBL] [Abstract][Full Text] [Related]
4. Progression of gastric enterochromaffin-like cells growth in Zollinger-Ellison syndrome and atrophic body gastritis patients.
Delle Fave G; Marignani M; Corleto VD; Angeletti S; D'Ambra G; Ferraro G; D'Adda T; Azzoni C; Jensen RT; Annibale B; Bordi C
Dig Liver Dis; 2002 Apr; 34(4):270-8. PubMed ID: 12038811
[TBL] [Abstract][Full Text] [Related]
5. Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas.
Jensen RT
Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):4-19. PubMed ID: 16433886
[TBL] [Abstract][Full Text] [Related]
6. Argyrophil cell hyperplasia and a carcinoid tumour in the stomach of a patient with sporadic Zollinger-Ellison syndrome.
Feurle GE
Gut; 1994 Feb; 35(2):275-7. PubMed ID: 8307483
[TBL] [Abstract][Full Text] [Related]
7. Hyperplastic, dysplastic, and neoplastic enterochromaffin-like-cell proliferations of the gastric mucosa. Classification and histogenesis.
Solcia E; Fiocca R; Villani L; Luinetti O; Capella C
Am J Surg Pathol; 1995; 19 Suppl 1():S1-7. PubMed ID: 7762735
[TBL] [Abstract][Full Text] [Related]
8. Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia.
Eissele R; Brunner G; Simon B; Solcia E; Arnold R
Gastroenterology; 1997 Mar; 112(3):707-17. PubMed ID: 9041231
[TBL] [Abstract][Full Text] [Related]
9. Enterochromaffin-like (ECL) cells and their growths: relationships to gastrin, reduced acid secretion and gastritis.
Solcia E; Rindi G; Silini E; Villani L
Baillieres Clin Gastroenterol; 1993 Mar; 7(1):149-65. PubMed ID: 7682874
[TBL] [Abstract][Full Text] [Related]
10. Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors.
Laine L; Ahnen D; McClain C; Solcia E; Walsh JH
Aliment Pharmacol Ther; 2000 Jun; 14(6):651-68. PubMed ID: 10848649
[TBL] [Abstract][Full Text] [Related]
11. Proton Pump Inhibitor Use, Hypergastrinemia, and Gastric Carcinoids-What Is the Relationship?
McCarthy DM
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963924
[TBL] [Abstract][Full Text] [Related]
12. Gastric carcinoids and related endocrine growths.
Solcia E; Capella C; Sessa F; Rindi G; Cornaggia M; Riva C; Villani L
Digestion; 1986; 35 Suppl 1():3-22. PubMed ID: 3539679
[TBL] [Abstract][Full Text] [Related]
13. Morphological changes of the human gastric mucosa under long-term proton pump inhibitor therapy and their clinical relevance.
Lamberts R
Microsc Res Tech; 2000 Mar; 48(6):357-66. PubMed ID: 10738317
[TBL] [Abstract][Full Text] [Related]
14. Gastric carcinoid tumors without autoimmune gastritis in Japan: a relationship with Helicobacter pylori infection.
Sato Y; Iwafuchi M; Ueki J; Yoshimura A; Mochizuki T; Motoyama H; Sugimura K; Honma T; Narisawa R; Ichida T; Asakura H; Van Thiel DH
Dig Dis Sci; 2002 Mar; 47(3):579-85. PubMed ID: 11911346
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiological effects of long-term acid suppression in man.
McCloy RF; Arnold R; Bardhan KD; Cattan D; Klinkenberg-Knol E; Maton PN; Riddell RH; Sipponen P; Walan A
Dig Dis Sci; 1995 Feb; 40(2 Suppl):96S-120S. PubMed ID: 7859587
[TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitors and Helicobacter pylori gastritis: friends or foes?
Kuipers EJ
Basic Clin Pharmacol Toxicol; 2006 Sep; 99(3):187-94. PubMed ID: 16930292
[TBL] [Abstract][Full Text] [Related]
17. [Effect of prolonged treatment with proton pump inhibitors on serum gastrin levels and the fundus mucosa. Preliminary results].
Cadiot G; Vissuzaine C; Pospai D; Ruszniewski P; Potet F; Mignon M
Gastroenterol Clin Biol; 1995 Oct; 19(10):811-7. PubMed ID: 8566561
[TBL] [Abstract][Full Text] [Related]
18. Old and New Gut Hormone, Gastrin and Acid Suppressive Therapy.
Haruma K; Kamada T; Manabe N; Suehiro M; Kawamoto H; Shiotani A
Digestion; 2018; 97(4):340-344. PubMed ID: 29587283
[TBL] [Abstract][Full Text] [Related]
19. Gastric cancer and gastrin: on the interaction of Helicobacter pylori gastritis and acid inhibitory induced hypergastrinemia.
Waldum HL; Rehfeld JF
Scand J Gastroenterol; 2019 Sep; 54(9):1118-1123. PubMed ID: 31524029
[TBL] [Abstract][Full Text] [Related]
20. Endocrine cell proliferation and carcinoid development: a review of new aspects of hypergastrinaemic atrophic gastritis.
Borch K; Renvall H; Liedberg G
Digestion; 1986; 35 Suppl 1():106-15. PubMed ID: 3539677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
